Samsung Biologics to acquire Switzerland’s PolyPeptide Group in $1.8 billion all-cash deal

🇰🇷 🇨🇭 BREAKING: Samsung Biologics to acquire Switzerland’s PolyPeptide Group in $1.8 billion all-cash deal. The acquisition is the largest biopharmaceutical M&A deal in the country’s history. Peptide therapeutics are medicines made from short chains of amino acids, including some GLP-1 obesity and diabetes drugs that mimic a natural hormone to reduce appetite and regulate blood sugar.

US Ramps Up: Ninth Night of Strikes Hits Iran Amid Rising Tensions

🇮🇷 🇺🇸 🚨 The US and Iran engaged in a quickening series of tit-for-tat attacks, with the US military carrying out its ninth consecutive night of strikes. US Central Command on Sunday announced the latest wave of attacks — along with the death of a third US service member in the past two days. Central Command described the recent American strikes as seeking to reduce Iran’s ability to threaten commercial shipping and “swiftly punish” IRGC forces.